Bio Plus Co., Ltd (KOSDAQ:099430)
5,260.00
+110.00 (2.14%)
Apr 10, 2026, 3:30 PM KST
Bio Plus Revenue
In the year 2025, Bio Plus had annual revenue of 90.90B KRW with 36.87% growth. Bio Plus had revenue of 23.18B in the quarter ending December 31, 2025, a decrease of -20.30%.
Revenue
90.90B
Revenue Growth
+36.87%
P/S Ratio
3.56
Revenue / Employee
n/a
Employees
n/a
Market Cap
323.70B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 90.90B | 24.49B | 36.87% |
| Dec 31, 2024 | 66.41B | 1.37B | 2.10% |
| Dec 31, 2023 | 65.04B | 8.32B | 14.68% |
| Dec 31, 2022 | 56.72B | 19.30B | 51.58% |
| Dec 31, 2021 | 37.42B | 13.05B | 53.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Seegene | 474.23B |
| i-SENS | 315.44B |
| InBody Co.,Ltd | 233.95B |
| WON TECH | 156.84B |
| Osang Healthcare Co.,Ltd | 128.63B |
| DRTECH | 116.30B |
| LabGenomics | 88.16B |
| Curexo | 74.53B |